Serial Number 97584986
Registration 7739694
700

Registration Progress

Application Filed
Sep 9, 2022
Under Examination
Dec 12, 2023
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered
Mar 25, 2025

Trademark Image

Basic Information

Serial Number
97584986
Registration Number
7739694
Filing Date
September 9, 2022
Registration Date
March 25, 2025
Published for Opposition
October 17, 2023
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 25, 2025
Registration
Registered
Classes
042

Rights Holder

INFINANT HEALTH, INC

03
Address
2121 2nd St, STE C108
Davis, CA 95618

Ownership History

Evolve BioSystems Inc.

Original Applicant
03
Davis, CA

INFINANT HEALTH, INC

New Owner Before Publication #1
03
Davis, CA

INFINANT HEALTH, INC

Owner at Publication
03
Davis, CA

INFINANT HEALTH, INC

Original Registrant
03
Davis, CA

Legal Representation

Attorney
John Gary Maynard, III

Application History

35 events
Date Code Type Description Documents
Mar 25, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 25, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 6, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 6, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 25, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 25, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 25, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 12, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 12, 2024 IUAF S USE AMENDMENT FILED Loading...
Dec 12, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 5, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 8, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 8, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 8, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 17, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 17, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 7, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 27, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 13, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly
First Use Anywhere: Jun 21, 2023
First Use in Commerce: Jun 21, 2023

Additional Information

Design Mark
The mark consists of six gold circles.
Color Claim
The color(s) gold is/are claimed as a feature of the mark.

Classification

International Classes
042